Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

682 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabine.
Pabst T, Vellenga E, van Putten W, Schouten HC, Graux C, Vekemans MC, Biemond B, Sonneveld P, Passweg J, Verdonck L, Legdeur MC, Theobald M, Jacky E, Bargetzi M, Maertens J, Ossenkoppele GJ, Löwenberg B; Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON); German AML Study Group (AMLSG); Swiss Collaborative Group for Clinical Cancer Research (SAKK). Pabst T, et al. Among authors: passweg j. Blood. 2012 Jun 7;119(23):5367-73. doi: 10.1182/blood-2011-11-389841. Epub 2012 Mar 15. Blood. 2012. PMID: 22422824 Free article. Clinical Trial.
High-dose chemotherapy using BEAM for tumor debulking without stem cell support followed by early allogeneic reduced intensity conditioning transplantation to induce a graft-versus-lymphoma effect in patients with high risk or refractory lymphoma.
Buser AS, Heim D, Bucher C, Tichelli A, Gratwohl A, Passweg JR. Buser AS, et al. Among authors: passweg jr. Bone Marrow Transplant. 2004 May;33(10):1011-4. doi: 10.1038/sj.bmt.1704489. Bone Marrow Transplant. 2004. PMID: 15064693 Clinical Trial.
Human leukocyte antigen DR15 is associated with reduced relapse rate and improved survival after human leukocyte antigen-identical sibling hematopoietic stem cell transplantation.
Stern M, Passweg J, Tiercy JM, Genitsch A, Meyer-Monard S, Heim D, Tichelli A, Gratwohl A, Nissen-Druey C. Stern M, et al. Among authors: passweg j. Biol Blood Marrow Transplant. 2006 Nov;12(11):1169-75. doi: 10.1016/j.bbmt.2006.07.001. Biol Blood Marrow Transplant. 2006. PMID: 17085310 Free article.
High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantation.
Buser AS, Stern M, Bucher C, Arber C, Heim D, Halter J, Meyer-Monard S, Stussi G, Lohri A, Ghielmini M, Tichelli A, Passweg JR, Gratwohl A. Buser AS, et al. Among authors: passweg jr. Bone Marrow Transplant. 2007 Mar;39(6):335-40. doi: 10.1038/sj.bmt.1705597. Bone Marrow Transplant. 2007. PMID: 17342158 Clinical Trial.
682 results